close
This ad will auto close in 10 seconds
Pharma giant Lupin embarks on generic drug treatment to treat depression in US

Pharma giant Lupin embarks on generic drug treatment to treat depression in US

We have launched generic Pristiq (Desvenlafaxine Succinate) extended-release tablets, 50 mg and 100 mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

Pharma major Lupin gets USFDA nod to market colonoscopy drugs, pain relief

Pharma major Lupin gets USFDA nod to market colonoscopy drugs, pain relief

The approved product is indicated for relief of moderate to moderately severe pain. Percocet tablets had US sales of USD 838.7 million.

Lupin receives USFDA nod for hypertension treatment drug in US

Lupin receives USFDA nod for hypertension treatment drug in US

Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.

Brokerage view on the stocks of 'Lupin, Idea, JP Morgan etc

Brokerage view on the stocks of 'Lupin, Idea, JP Morgan etc. Watch this special segment and get to know more here.

Lupin gets USFDA tentative nod for anti-bacterial tablets

Lupin gets USFDA tentative nod for anti-bacterial tablets

 Drug firm Lupin has received tentative approval from the US health regulator to market its generic anti-bacterial moxifloxacin hydrochloride tablets in the American market.

 TCS, Infosys in Forbes 'Super 50' list; Tata Motors, HUL dropped

TCS, Infosys in Forbes 'Super 50' list; Tata Motors, HUL dropped

Software majors TCS and Infosys, pharma giants Sun Pharma and Lupin and private sector lenders HDFC Bank and Axis Bank feature in Forbes India's Super 50 List this year, while biggies like Tata Motors and HUL have been dropped.

USFDA clears Lupin's Goa facility; stocks up 6.25%

USFDA clears Lupin's Goa facility; stocks up 6.25%

Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.

Committed to close corrective action at Goa by Dec: Lupin

Committed to close corrective action at Goa by Dec: Lupin

New Delhi: Drug major Lupin has committed to close the corrective action at its Goa facility, which had received nine observations from US health regulator, by December.

Lupin to market Novartis' inhaler under Loftair brand name

Lupin to market Novartis' inhaler under Loftair brand name

Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India

Lupin launches generic insomnia drug in US

Drug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.

Lupin launches generic Aricept tablets in US market

Lupin launches generic Aricept tablets in US market

Drug major Lupin has launched Donepezil Hydrochloride tablets, used in treating Alzheimer's disease, in the US market after having received the US health regulator USFDA's nod for the product earlier

Lupin shares hit 52-week low; tank over 14%

Lupin shares hit 52-week low; tank over 14%

 Shares of pharma firm Lupin today tumbled over 14 per cent to hit their one-year low level amid reports of regulatory concerns at one of its unit.

10 best companies to work for in India

10 Indian companies made it to the list under the '25 Best Large Places to Work'

Lupin receives nine observations from USFDA for Goa plant

Drug major Lupin on Tuesday says that it has received nine observations relating to inadequacy and adherence to operating norms for its manufacturing plant in Goa from the US Food and Drug Administration (USFDA)

Expert view on Lupin stocks

Expert view on Lupin stocks

Expert view on Lupin stocks

Lupin Q3 net profit dips 12% to Rs 530 crore

The company had posted a net profit of Rs 601.45 crore in the same period of the previous fiscal.

Aapka Bazaar: Investors' Query On Walchand Nagar, Cairn India and Lupin

Our Zee Business viewers call us on our daily show to ask their investment related queries. Today our caller asked us their query related to Walchand Nagar, Cairn India and Lupin

Lupin appoints Martin Mercer as head of Latin American biz

Drug major Lupin Monday appointed Martin Mercer as President of its Latin American business with immediate effect.

Lupin, Boehringer Ingelheim to co-market linagliptin in India

Drug majors Lupin and Boehringer Ingelheim on Wednesday announced a strategic alliance to co-market anti-diabetes drug linagliptin in India.

India drugmaker stocks exception in Asian rout

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.